v3.25.2
Consolidated Statements of Changes in Stockholders' Equity (Unaudited) - USD ($)
shares in Thousands
Total
Parent
Common stock
Treasury stock
Additional paid-in capital
Accumulated deficit
Accumulated other comprehensive loss
Noncontrolling interest
Beginning balance (in shares) at Dec. 31, 2023     51,770          
Increase (Decrease) in Stockholders' Equity                
Common stock issued upon vesting of restricted stock (in shares)     404          
Common stock issued for ESPP purchases (in shares)     56          
Common stock sold through offerings (in shares)     0          
Ending balance (in shares) at Jun. 30, 2024     52,230          
Beginning balance, treasury stock (in shares) at Dec. 31, 2023       6,356        
Increase (Decrease) in Stockholders' Equity                
Repurchases of common stock (in shares)       0        
Tax withholding upon vesting of employee stock awards (in shares)       124        
Ending balance, treasury stock (in shares) at Jun. 30, 2024       6,480        
Beginning balance at Dec. 31, 2023     $ 5,000 $ (166,345,000) $ 1,007,649,000 $ (481,671,000) $ (506,000) $ 0
Increase (Decrease) in Stockholders' Equity                
Common stock sold through offerings     0   0      
Stock-based compensation to employees and directors         10,035,000      
Common stock issued for ESPP purchases         935,000      
Consolidated net loss $ (116,506,000)         (116,506,000)    
Net other comprehensive income 8,000           8,000  
Repurchases of common stock       0        
Tax withholding upon vesting of employee stock awards       (3,250,000)        
Proceeds from security token offering, net               0
Net loss attributable to noncontrolling interests 0             0
Ending balance at Jun. 30, 2024 250,354,000 $ 250,354,000 $ 5,000 $ (169,595,000) 1,018,619,000 (598,177,000) (498,000) 0
Beginning balance (in shares) at Mar. 31, 2024     52,210          
Increase (Decrease) in Stockholders' Equity                
Common stock issued upon vesting of restricted stock (in shares)     20          
Common stock issued for ESPP purchases (in shares)     0          
Common stock sold through offerings (in shares)     0          
Ending balance (in shares) at Jun. 30, 2024     52,230          
Beginning balance, treasury stock (in shares) at Mar. 31, 2024       6,477        
Increase (Decrease) in Stockholders' Equity                
Repurchases of common stock (in shares)       0        
Tax withholding upon vesting of employee stock awards (in shares)       3        
Ending balance, treasury stock (in shares) at Jun. 30, 2024       6,480        
Beginning balance at Mar. 31, 2024     $ 5,000 $ (169,517,000) 1,013,360,000 (555,599,000) (502,000) 0
Increase (Decrease) in Stockholders' Equity                
Common stock sold through offerings     0   0      
Stock-based compensation to employees and directors         5,259,000      
Common stock issued for ESPP purchases         0      
Consolidated net loss (42,578,000)         (42,578,000)    
Net other comprehensive income 4,000           4,000  
Repurchases of common stock       0        
Tax withholding upon vesting of employee stock awards       (78,000)        
Proceeds from security token offering, net               0
Net loss attributable to noncontrolling interests 0             0
Ending balance at Jun. 30, 2024 $ 250,354,000 250,354,000 $ 5,000 $ (169,595,000) 1,018,619,000 (598,177,000) (498,000) 0
Increase (Decrease) in Stockholders' Equity                
Common stock, shares outstanding (in shares)     45,750          
Common stock, shares outstanding (in shares) 53,069              
Beginning balance (in shares) at Dec. 31, 2024     59,560          
Increase (Decrease) in Stockholders' Equity                
Common stock issued upon vesting of restricted stock (in shares)     339          
Common stock issued for ESPP purchases (in shares)     91          
Common stock sold through offerings (in shares)     4,332          
Ending balance (in shares) at Jun. 30, 2025     64,322          
Beginning balance, treasury stock (in shares) at Dec. 31, 2024 6,491     6,491        
Increase (Decrease) in Stockholders' Equity                
Repurchases of common stock (in shares)       333        
Tax withholding upon vesting of employee stock awards (in shares)       93        
Ending balance, treasury stock (in shares) at Jun. 30, 2025 6,917     6,917        
Beginning balance at Dec. 31, 2024 $ 162,732,000   $ 5,000 $ (169,676,000) 1,072,869,000 (740,466,000) 0 0
Increase (Decrease) in Stockholders' Equity                
Common stock sold through offerings     1,000   24,221,000      
Stock-based compensation to employees and directors         4,480,000      
Common stock issued for ESPP purchases         509,000      
Consolidated net loss (59,225,000)         (59,225,000)    
Net other comprehensive income 0           0  
Repurchases of common stock (1,300,000)     (1,311,000)        
Tax withholding upon vesting of employee stock awards       (539,000)        
Proceeds from security token offering, net               337,000
Net loss attributable to noncontrolling interests 0             0
Ending balance at Jun. 30, 2025 $ 131,205,000 130,868,000 $ 6,000 $ (171,526,000) 1,102,079,000 (799,691,000) 0 337,000
Beginning balance (in shares) at Mar. 31, 2025     63,413          
Increase (Decrease) in Stockholders' Equity                
Common stock issued upon vesting of restricted stock (in shares)     64          
Common stock issued for ESPP purchases (in shares)     0          
Common stock sold through offerings (in shares)     845          
Ending balance (in shares) at Jun. 30, 2025     64,322          
Beginning balance, treasury stock (in shares) at Mar. 31, 2025       6,581        
Increase (Decrease) in Stockholders' Equity                
Repurchases of common stock (in shares)       333        
Tax withholding upon vesting of employee stock awards (in shares)       3        
Ending balance, treasury stock (in shares) at Jun. 30, 2025 6,917     6,917        
Beginning balance at Mar. 31, 2025     $ 6,000 $ (170,203,000) 1,093,943,000 (780,378,000) 0 0
Increase (Decrease) in Stockholders' Equity                
Common stock sold through offerings     0   4,750,000      
Stock-based compensation to employees and directors         3,386,000      
Common stock issued for ESPP purchases         0      
Consolidated net loss $ (19,313,000)         (19,313,000)    
Net other comprehensive income 0           0  
Repurchases of common stock (1,300,000)     (1,311,000)        
Tax withholding upon vesting of employee stock awards       (12,000)        
Proceeds from security token offering, net               337,000
Net loss attributable to noncontrolling interests 0             0
Ending balance at Jun. 30, 2025 $ 131,205,000 $ 130,868,000 $ 6,000 $ (171,526,000) $ 1,102,079,000 $ (799,691,000) $ 0 $ 337,000
Increase (Decrease) in Stockholders' Equity                
Common stock, shares outstanding (in shares) 57,405   57,405